Computer-assisted prescription of erythropoiesis-stimulating agents in patients undergoing maintenance hemodialysis: a randomized control trial for artificial intelligence model selection.
Machine learning (ML) algorithms are promising tools for managing anemia in hemodialysis (HD) patients. However, their efficacy in predicting erythropoiesis-stimulating agents (ESAs) doses remains uncertain. This study aimed to evaluate the effectiveness of a contemporary artificial intelligence (AI) model in prescribing ESA doses compared to physicians for HD patients.
Author(s): Lim, Lee-Moay, Lin, Ming-Yen, Hsu, Chan, Ku, Chantung, Chen, Yi-Pei, Kang, Yihuang, Chiu, Yi-Wen
DOI: 10.1093/jamiaopen/ooaf020